Scholars@Duke

Bevacizumab plus interferon-α improves survival: Commentary

Publication ,  Other
George, DJ; Moul, JW
Published in: Oncology Report
September 1, 2007

Duke Scholars

Daniel James George
Author Daniel James George Medicine, Medical Oncology
Judd Wendell Moul
Author Judd Wendell Moul Urology

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2007

Issue

FALL

Start / End Page

57

Related Subject Headings

  • Oncology & Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
George, D. J., & Moul, J. W. (2007). Bevacizumab plus interferon-α improves survival: Commentary. Oncology Report.
George, D. J., and J. W. Moul. “Bevacizumab plus interferon-α improves survival: Commentary.” Oncology Report, September 1, 2007.
George DJ, Moul JW. Bevacizumab plus interferon-α improves survival: Commentary. Oncology Report. 2007. p. 57.
George, D. J., and J. W. Moul. “Bevacizumab plus interferon-α improves survival: Commentary.” Oncology Report, no. FALL, 1 Sept. 2007, p. 57.
George DJ, Moul JW. Bevacizumab plus interferon-α improves survival: Commentary. Oncology Report. 2007. p. 57.

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2007

Issue

FALL

Start / End Page

57

Related Subject Headings

  • Oncology & Carcinogenesis